Controlled evaluation of drugs in chronic vascular disease.
D000721:Ancrod / Q000627:therapeutic use; D012103:Batroxobin / Q000627:therapeutic use; D001809:Blood Viscosity / Q000187:drug effects; D002196:Capillaries / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003097:Collateral Circulation / Q000187:drug effects; D003911:Dextrans / Q000627:therapeutic use; D004311:Double-Blind Method; D006801:Humans; D008833:Microcirculation / Q000187:drug effects; D010991:Plethysmography; D011897:Random Allocation; D012212:Rheology; D014463:Ultrasonography; D014652:Vascular Diseases / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D003911:Dextrans; D014665:Vasodilator Agents; D000721:Ancrod; D012103:Batroxobin